OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.
about
Current status and future directions of botulinum neurotoxins for targeting pain processingBotulinum Toxin Type a as a Therapeutic Agent against Headache and Related DisordersTreatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and SafetyUpdate on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options.Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction.Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays.Brain Changes in Responders vs. Non-Responders in Chronic Migraine: Markers of Disease Reversal.Time course analysis of the effects of botulinum neurotoxin type A on pain and vasomotor responses evoked by glutamate injection into human temporalis muscles.A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.Latin American consensus on guidelines for chronic migraine treatment.Emerging therapies for chronic migraine.OnabotulinumtoxinA Injections for the Treatment of Cyclic Vomiting Syndrome.Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update.Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine.OnabotulinumtoxinA (BOTOX®): a guide to its use in preventing headaches in adults with chronic migraine.OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.
P2860
Q26778129-7CCECAE9-AC1F-494D-ADBF-088B22401F93Q26781281-ADD2E7B7-037E-4585-8F4B-8BFEAC745D16Q26801753-912794B4-8452-4C1B-8976-DA782BCEF500Q30391958-00CC230E-9D93-4177-A64A-176AF67BFC33Q33957870-D576694D-D026-4F13-8E1B-B68AA4C7BBECQ34960591-C2F7582F-15B2-4554-B967-DFA185D992BFQ36223269-45050575-4A0C-4CA0-856A-6F754C98E246Q37314099-387C668E-CA28-490F-BD42-D23B7CA3860AQ37617800-92F9F84D-30C5-4B35-8A9F-44F4DE146CD6Q38118652-9F7EA96A-2AFD-4C71-B763-E7436EB0D6A1Q38121835-80BBBBD1-90B2-489D-9DE6-91AA27CBEB81Q38187606-770EA1C7-0E27-4A2D-B449-2E24C262826CQ38396223-A9458127-9CDC-40B3-9859-FA820A9BD335Q38676482-21A7349E-FBA6-4C7C-97E5-407331C39877Q47410678-E9BD1E11-7582-4E27-92A2-826C287A4776Q48418075-3164B2D3-7206-48F6-AE19-4DEAF0D4B3EFQ52658935-89CB7161-DE2C-4758-B913-BFD44DEFD543
P2860
OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
OnabotulinumtoxinA (BOTOX®): a ...... adults with chronic migraine.
@en
type
label
OnabotulinumtoxinA (BOTOX®): a ...... adults with chronic migraine.
@en
prefLabel
OnabotulinumtoxinA (BOTOX®): a ...... adults with chronic migraine.
@en
P2860
P1433
P1476
OnabotulinumtoxinA (BOTOX®): a ...... adults with chronic migraine.
@en
P2093
James E Frampton
P2860
P304
P356
10.2165/11208880-000000000-00000
P577
2012-04-01T00:00:00Z
P6179
1032133846